Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 84, Issue 6, 2005, Pages 1755-1757

  Lucidi, R Scott ^a,b   Thyer, Angela C ^a   Easton, Carol A ^a   Holden, Alan E C ^a   Schenken, Robert S ^a   Brzyski, Robert G ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENSTRUAL CYCLE; OVARY; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; IRON CHELATING AGENTS; MENSTRUAL CYCLE; OVARY; OVULATION; PICOLINIC ACIDS; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME;

EID: 28944448773     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.06.028     Document Type: Article

References (22)

1. E.S. Knochenhauer, T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, R. Azziz Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States a prospective study J Clin Endocrinol Metab 83 1998 3078 3082
2. C.G. Solomon The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks Endocrinol Metab Clin North Am 28 1999 247 263
3. G.S. Conway, J.W. Honour, H.S. Jacobs Heterogeneity of the polycystic ovary syndrome clinical, endocrine and ultrasound features in 556 patients Clin Endocrinol 30 1989 459 470
4. J.E. Nestler, D.J. Jakubowicz Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens J Clin Endocrinol Metab 82 1997 4075 4079
5. H. Grulet, A.C. Hecart, B. Delemer, A. Gross, V. Sulmont, M. Leutenegger Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome Clin Endocrinol 38 1993 621 626
6. A. Dunaif, K.R. Segal, W. Futterweit, A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
7. V. Sepilian, M. Nagamani Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance J Clin Endocrinol Metab 90 2005 60 65
8. L.C. Morin-Papunen, R.M. Koivunen, A. Ruokonen, H.K. Martikainen Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome Fertil Steril 69 1998 691 696
9. J.E. Nestler, D.J. Jakubowicz, W.S. Evans, R. Pasquali Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome N Engl J Med 338 1998 1876 1880
10. N. Brettenthaler, C. De Geyter, P.R. Huber, U. Keller Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 3835 3840
11. N.A. Cataldo, F. Abbasi, T.L. McLaughlin, C. Lamendola, G.M. Reaven Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone Fertil Steril 76 2001 1057 1059
12. J.P. Baillargeon, D.J. Jakubowicz, M.J. Iuorno, S. Jakubowicz, J.E. Nestler Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity Fertil Steril 82 2004 893 902
13. C.J. Glueck, A. Moreira, N. Goldenberg, L. Sieve, P. Wang Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin Hum Reprod 18 2003 1618 1625
14. K.N. Jeejeebhoy, R.C. Chu, E.B. Marliss, G.R. Greenberg, A. Bruce-Robertson Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition Am J Clin Nutr 30 1977 531 538
15. W. Mertz Chromium research from a distance from 1959 to 1980 J Am Coll Nutr 17 1998 544 547
16. C.M. Davis, J.B. Vincent Chromium oligopeptide activates insulin receptor tyrosine kinase activity Biochemistry 36 1997 4382 4385
17. J.B. Vincent Mechanisms of chromium action low-molecular-weight chromium-binding substance J Am Coll Nutr 18 1999 6 12
18. R.A. Anderson, M.M. Polansky, N.A. Bryden, J.J. Canary Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets Am J Clin Nutr 54 1991 909 916
19. R.A. Anderson, N. Cheng, N.A. Bryden, M.M. Polansky, J. Chi, J. Feng Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes Diabetes 46 1997 1786 1791
20. R.N. Bergman, Y.Z. Ider, C.R. Bowden, C. Cobelli Quantitative estimation of insulin sensitivity Am J Physiol 236 1979 E667 E677
21. R.A. Anderson Chromium, glucose intolerance and diabetes J Am Coll Nutr 17 1998 548 555
22. J. Goldzieher, J. Green The polycystic ovary. I. Clinical and histologic features J Clin Endocrinol Metab 22 1962 325 338